Pro Medicus Crecimiento futuro
Future controles de criterios 5/6
Pro Medicus se prevé un crecimiento anual de los beneficios y los ingresos de 19% y 17.5% respectivamente. Se prevé que el BPA sea de grow en 19% al año. Se prevé que la rentabilidad de los fondos propios sea de 45.1% en 3 años.
Información clave
20.3%
Tasa de crecimiento de los beneficios
20.3%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare Services | 26.0% |
| Tasa de crecimiento de los ingresos | 17.9% |
| Rentabilidad financiera futura | 45.1% |
| Cobertura de analistas | Good |
| Última actualización | 04 Apr 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Here's Why We Think Pro Medicus (ASX:PME) Might Deserve Your Attention Today
Jan 15
Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Dec 10Here's Why Pro Medicus (ASX:PME) Has Caught The Eye Of Investors
Oct 09Why The 47% Return On Capital At Pro Medicus (ASX:PME) Should Have Your Attention
Aug 12Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Jul 08Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)
May 09Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?
Apr 02Pro Medicus (ASX:PME) Is Achieving High Returns On Its Capital
Jan 25We Ran A Stock Scan For Earnings Growth And Pro Medicus (ASX:PME) Passed With Ease
Dec 13Returns on Capital Paint A Bright Future For Pro Medicus (ASX:PME)
Oct 26Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Sep 14Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Jul 06Here's Why We Think Pro Medicus (ASX:PME) Is Well Worth Watching
Jun 15Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?
Mar 16Investors Should Be Encouraged By Pro Medicus' (ASX:PME) Returns On Capital
Feb 23Is Now The Time To Put Pro Medicus (ASX:PME) On Your Watchlist?
Oct 26Pro Medicus (ASX:PME) Knows How To Allocate Capital Effectively
Aug 13Do Pro Medicus's (ASX:PME) Earnings Warrant Your Attention?
Jul 26Pro Medicus (ASX:PME) Is Investing Its Capital With Increasing Efficiency
May 07Pro Medicus Limited's (ASX:PME) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Mar 15This Insider Has Just Sold Shares In Pro Medicus Limited (ASX:PME)
Feb 20Pro Medicus Limited Just Missed EPS By 14%: Here's What Analysts Think Will Happen Next
Feb 18
Is Pro Medicus (ASX:PME) The Next Multi-Bagger?
Feb 01How Much Did Pro Medicus' (ASX:PME) CEO Pocket Last Year?
Jan 12Should You Be Adding Pro Medicus (ASX:PME) To Your Watchlist Today?
Dec 28Pro Medicus (ASX:PME) Has Rewarded Shareholders With An Exceptional 825% Total Return On Their Investment
Dec 11Is Pro Medicus Limited's (ASX:PME) Shareholder Ownership Skewed Towards Insiders?
Nov 26Pro Medicus's (ASX:PME) Earnings Are Growing But Is There More To The Story?
Aug 09What Kind Of Shareholders Hold The Majority In Pro Medicus Limited's (ASX:PME) Shares?
Aug 09Does Pro Medicus (ASX:PME) Have The DNA Of A Multi-Bagger?
Jul 21How Much Are Pro Medicus Limited (ASX:PME) Insiders Taking Off The Table?
Jul 03Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 6/30/2026 | 250 | 131 | 119 | 128 | 12 |
| 6/30/2025 | 203 | 104 | 96 | 103 | 12 |
| 6/30/2024 | 161 | 79 | 75 | 81 | 12 |
| 12/31/2023 | 142 | 70 | 65 | 71 | N/A |
| 9/30/2023 | 134 | 65 | 60 | 67 | N/A |
| 6/30/2023 | 125 | 61 | 56 | 63 | N/A |
| 3/31/2023 | 115 | 56 | 51 | 59 | N/A |
| 12/31/2022 | 106 | 51 | 47 | 55 | N/A |
| 9/30/2022 | 100 | 48 | 50 | 58 | N/A |
| 6/30/2022 | 93 | 44 | 53 | 62 | N/A |
| 3/31/2022 | 87 | 41 | 47 | 55 | N/A |
| 12/31/2021 | 81 | 38 | 41 | 49 | N/A |
| 9/30/2021 | 74 | 34 | 36 | 44 | N/A |
| 6/30/2021 | 68 | 31 | 31 | 39 | N/A |
| 3/31/2021 | 64 | 28 | 27 | 36 | N/A |
| 12/31/2020 | 59 | 25 | 24 | 32 | N/A |
| 9/30/2020 | 58 | 24 | 24 | 32 | N/A |
| 6/30/2020 | 57 | 23 | 24 | 31 | N/A |
| 3/31/2020 | 55 | 23 | 25 | 33 | N/A |
| 12/31/2019 | 54 | 22 | 27 | 34 | N/A |
| 9/30/2019 | 52 | 21 | 22 | 30 | N/A |
| 6/30/2019 | 50 | 19 | 17 | 25 | N/A |
| 3/31/2019 | 47 | 17 | N/A | N/A | N/A |
| 12/31/2018 | 43 | 16 | 7 | 14 | N/A |
| 9/30/2018 | 39 | 13 | 7 | 14 | N/A |
| 6/30/2018 | 34 | 10 | 7 | 14 | N/A |
| 3/31/2018 | 33 | 9 | N/A | N/A | N/A |
| 12/31/2017 | 32 | 8 | 8 | 15 | N/A |
| 9/30/2017 | 32 | 9 | N/A | 15 | N/A |
| 6/30/2017 | 32 | 9 | N/A | 15 | N/A |
| 3/31/2017 | 30 | 9 | N/A | 13 | N/A |
| 12/31/2016 | 28 | 8 | N/A | 12 | N/A |
| 9/30/2016 | 28 | 7 | N/A | 11 | N/A |
| 6/30/2016 | 28 | 6 | N/A | 11 | N/A |
| 3/31/2016 | 25 | 5 | N/A | 9 | N/A |
| 12/31/2015 | 23 | 5 | N/A | 8 | N/A |
| 9/30/2015 | 20 | 4 | N/A | 6 | N/A |
| 6/30/2015 | 17 | 3 | N/A | 4 | N/A |
| 3/31/2015 | 17 | 3 | N/A | 4 | N/A |
| 12/31/2014 | 17 | 3 | N/A | 4 | N/A |
| 9/30/2014 | 16 | 2 | N/A | 4 | N/A |
| 6/30/2014 | 14 | 2 | N/A | 4 | N/A |
| 12/31/2013 | 11 | 1 | N/A | 6 | N/A |
| 9/30/2013 | 11 | -1 | N/A | 5 | N/A |
| 6/30/2013 | 11 | -3 | N/A | 4 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: PME(19% al año) es superior a la tasa de ahorro (2.1%).
Beneficios vs. Mercado: PMESe prevé que los beneficios de la empresa (19% al año) crezcan más deprisa que el mercado Australian (8.8% al año).
Beneficios de alto crecimiento: PMESe espera que los beneficios de la empresa crezcan significativamente en los próximos 3 años.
Ingresos vs. Mercado: PMESe prevé que los ingresos de la empresa (17.5% al año) crezcan más deprisa que los del mercado Australian (4% al año).
Ingresos de alto crecimiento: PMESe prevé que los ingresos de la empresa (17.5% al año) crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: PMESe prevé que la Rentabilidad de los fondos propios de la empresa sea muy elevada dentro de 3 años (45.1%).